McGranahan, N;
Swanton, C;
(2019)
Neoantigen quality, not quantity.
Science Translational Medicine
, 11
(506)
, Article eaax7918. 10.1126/scitranslmed.aax7918.
Preview |
Text
McGranahan NM_CS2_Final{aax7918_final edits.pdf - Accepted Version Download (651kB) | Preview |
Abstract
Prioritizing expressed clonal neoantigens in genes required for cancer cell survival may reduce the likelihood of resistance to neoantigen therapies.
| Type: | Article |
|---|---|
| Title: | Neoantigen quality, not quantity |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1126/scitranslmed.aax7918 |
| Publisher version: | https://doi.org/10.1126/scitranslmed.aax7918 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10083356 |
Downloads since deposit
1,192Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
